Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Frýdlová, Jana ^a   Pøikryl, Petr ^a   Truksa, Jaroslav ^b   Falke, Lucas L ^c   Du, Xin ^d   Gurieva, Iuliia ^a   Vokurka, Martin ^a   Krijt, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOJUVELIN; HEPCIDIN; IRON; MATRIPTASE; PROTEIN TMPRSS6; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BONE MORPHOGENETIC PROTEIN 6; HFE2 PROTEIN, MOUSE; MATRIPTASE 2; MEMBRANE PROTEIN; SERINE PROTEINASE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CENTRIFUGATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HEPCIDIN GENE; IMMUNOBLOTTING; IRON DEFICIENCY; IRON OVERLOAD; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; STABLE EXPRESSION; ANIMAL; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; IRON DEFICIENCY ANEMIA; KNOCKOUT MOUSE; LIVER; METABOLISM; MUTATION;

ANEMIA, IRON-DEFICIENCY; ANIMALS; BONE MORPHOGENETIC PROTEIN 6; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; FEMALE; IRON; IRON OVERLOAD; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; RATS; SERINE ENDOPEPTIDASES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84958811849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148540     Document Type: Article

References (47)

1. Finberg KE. Iron-refractory iron deficiency anemia. Semin Hematol. 2009; 46(4):378-86. doi: 10.1053/j. seminhematol.2009.06.006 PMID: 19786206
2. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008 May 23; 320(5879):1088-92. doi: 10.1126/science.1157121 PMID: 18451267
3. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008 May; 40(5):569-71. doi: 10.1038/ng.130 PMID: 18408718
4. Folgueras AR, De Lara FM, Pendás AM, Garabaya C, Rodríguez F, Astudillo A, et al. Membrane-bound serine protease matriptase-2 (TMPRSS6) is an essential regulator of iron homeostasis. Blood. 2008 Sep 15; 112(6):2539-45. doi: 10.1182/blood-2008-04-149773 PMID: 18523150
5. Guillem F, Lawson S, Kannengiesser C, Westerman M, Beaumont C, Grandchamp B. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood. 2008; 112(5):2089-91. doi: 10.1182/blood-2008-05-154740 PMID: 18596229
6. Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica. 2008 Oct; 93(10):1473-9. doi: 10.3324/haematol.13342 PMID: 18603562
7. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013; 93(4):1721-41. doi: 10.1152/physrev.00008. 2013 PMID: 24137020
8. Béliveau F, Désilets A, Leduc R. Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. FEBS J. 2009; 276(8):2213-26. doi: 10. 1111/j.1742-4658.2009.06950.x PMID: 19302215
9. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matripase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Met. 2008; 8 (6):502-511.
10. Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, Wang RH, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood. 2008; 112(4):1503-9. doi: 10.1182/blood-2008-03-143354 PMID: 18539898
11. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006; 38(5):531-9. PMID: 16604073
12. Truksa J, Gelbart T, Peng H, Beutler E, Beutler B, Lee P. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. Br J Haematol. 2009; 147(4):571-81. doi: 10.1111/j.1365-2141.2009.07873.x PMID: 19751239
13. Zhang AS, Anderson SA, Wang J, Yang F, DeMaster K, Ahmed R, et al. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. Blood. 2011; 117(5):1687-99. doi: 10.1182/blood-2010-06-287292 PMID: 21115976
14. Lakhal S, Schödel J, Townsend AR, Pugh CW, Ratcliffe PJ, Mole DR. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: New link between hypoxia signaling and iron homeostasis. J Biol Chem.2011; 286(6):4090-7. doi: 10.1074/jbc.M110.173096 PMID: 20966077
15. Maurer E, Gütschow M, Stirnberg M. Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: Identification of a hypoxia-responsive element in the TMPRSS6 promoter region. Biol Chem. 2012; 393(6):535-40. doi: 10.1515/hsz-2011-0221 PMID: 22628316
16. Meynard D, Vaja V, Sun CC, Corradini E, Chen S, López-Otín C, et al. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood. 2011; 118(3):747-56. doi: 10.1182/blood-2011-04-348698 PMID: 21622652
17. Daba A, Gkouvatsos K, Sebastiani G, Pantopoulos K. Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: Compartmentalization is critical for iron sensing. J Mol Med (Berl). 2013; 91(1):95-102.
18. Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest. 2005; 115(8):2180-6. PMID: 16075058
19. Dendooven A, Van Oostrom O, Van Der Giezen DM, Leeuwis JW, Snijckers C, Joles JA, et al. Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol. 2011; 178(3):1069-79. doi: 10.1016/j.ajpath.2010.12.005 PMID: 21356359
20. Wisniewski JR. Protocol to enrich and analyze plasma membrane proteins. In: Peirce MJ, Wait R, editors. Membrane Proteomics: Methods and Protocols, vol. 528. Humana Press; 2009. p. 127-134.
21. Frýdlová J, Fujikura Y, Vokurka M, Ne?as E, Krijt J. Decreased hemojuvelin protein levels in mask mice lacking matriptase-2-dependent proteolytic activity. Physiol Res. 2013; 62(4):405-11. PMID: 23590607
22. Torrance JD, Bothwell TH. Tissue iron stores. In: Cook JD, editor. Methods in hematology, Vol. 1. New York: Churchill Livingstone; 1981. p. 90-115.
23. Krijt J, Fujikura Y, Ramsay AJ, Velasco G, Ne?as E. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (TMPRSS6). Blood Cells Mol Dis. 2011; 47(2):133-7. PMID: 21612955
24. Maxson JE, Enns CA, Zhang AS. Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cells. Blood. 2009; 113(8):1786-93. doi: 10.1182/blood-2008-08-174565 PMID: 19029439
25. Enns CA, Ahmed R, Zhang AS. Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage. J Biol Chem. 2012; 287(42):35104-17. doi: 10.1074/jbc.M112.363937 PMID: 22893705
26. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, López-Otín C. Matriptase-2 (TMPRSS6): A proteolytic regulator of iron homeostasis. Haematologica. 2009; 94(6):840-9. doi: 10.3324/haematol.2008. 001867 PMID: 19377077
27. Velasco G, Cal S, Quesada V, Sánchez LM, López-Otín C. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem. 2002; 277(40):37637-46. PMID: 12149247
28. Jiang J, Yang J, Feng P, Zuo B, Dong N, Wu Q, et al. N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding. J Biol Chem. 2014; 289(28):19500-7. doi: 10.1074/jbc.M114. 555110 PMID: 24867957
29. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009; 41(4):478-81. doi: 10.1038/ng. 320 PMID: 19252488
30. Andriopoulos B Jr, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009; 41(4):482-7. doi: 10. 1038/ng.335 PMID: 19252486
31. Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, Ginzburg Y, et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology. 2011; 53(4):1333-41. doi: 10.1002/hep.24178 PMID: 21480335
32. Corradini E, Meynard D, Wu Q, Chen S, Ventura P, Pietrangelo A, et al. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology. 2011; 54(1):273-84. doi: 10.1002/hep.24359 PMID: 21488083
33. McDonald CJ, Wallace DF, Ostini L, Subramaniam VN. Parenteral vs. oral iron: Influence on hepcidin signaling pathways through analysis of Hfe/Tfr2-null mice. Am J Physiol Gastrointest Liver Physiol. 2014; 306(2):G132-9. doi: 10.1152/ajpgi.00256.2013 PMID: 24284962
34. Krijt J, Frýdlová J, Kuka?ková L, Fujikura Y, P?ikryl P, Vokurka M, et al. Effect of iron overload and iron deficiency on liver hemojuvelin protein. PLoS One. 2012; 7(5):e37391. doi: 10.1371/journal.pone. 0037391 PMID: 22629388
35. Lee DH, Zhou LJ, Zhou Z, Xie JX, Jung JU, Liu Y, et al. Neogenin inhibits HFE2 secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood. 2010; 115(15):3136-45. doi: 10.1182/blood-2009-11-251199 PMID: 20065295
36. Zhao N, Nizzi CP, Anderson SA, Wang J, Ueno A, Tsukamoto H, et al. Low intracellular iron increases the stability of matriptase-2. J Biol Chem. 2015; 290(7):4432-46. doi: 10.1074/jbc.M114.611913 PMID: 25550162
37. Nili M, Shinde U, Rotwein P. Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2-and BMP6-mediated signaling and gene expression. J Biol Chem. 2010; 285(32):24783-92. doi: 10.1074/jbc.M110.130286 PMID: 20530805
38. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002; 29(3):327-35. PMID: 12547223
39. Krijt J, Joná?ová A, Neuwirtová R, Ne?as E. Effect of erythropoietin on hepcidin expression in hemojuvelin-mutant mice. Blood Cells Mol Dis. 2010; 44(4):257-61. doi: 10.1016/j.bcmd.2010.02.012 PMID: 20219396
40. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46(7):678-84. doi: 10.1038/ng.2996 PMID: 24880340
41. Nicolas G, Deschemin JC, Ramsay AJ, Mayeux P, Grandchamp B, Beaumont C, et al. Is EPO therapy able to correct iron deficiency anaemia caused by matriptase-2 deficiency? Br J Haematol. 2011 Feb; 152(4):498-500. doi: 10.1111/j.1365-2141.2010.08473.x PMID: 21223251
42. Lee P. EPO-mediated reduction in Hamp expression in vivo corrects iron deficiency anemia in TMPRSS6 deficiency [erratum]. Br J Haematol. 2012; 156(3):415-6.
43. Lehmberg K, Grosse R, Muckenthaler MU, Altamura S, Nielsen P, Schmid H, et al. Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients. Ann Hematol. 2013; 92(3):387-94. doi: 10.1007/s00277-012-1618-8 PMID: 23180434
44. Finch C. Regulators of iron balance in humans. Blood. 1994; 84(6):1697-702. PMID: 8080980
45. Nai A, Pagani A, Mandelli G, Lidonnici MR, Silvestri L, Ferrari G et al. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of ?-thalassemia. Blood. 2012; 119(21):5021-9. doi: 10.1182/blood-2012-01-401885 PMID: 22490684
46. Willemetz A, Lenoir A, Deschemin JC, Lopez-Otin C, Ramsay AJ, Vaulont S, et al. Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis. Blood. 2014; 124(3):441-4. doi: 10.1182/blood-2014-01-551150 PMID: 24904115
47. Keel SB, Doty R, Liu L, Nemeth E, Cherian S, Ganz T, et al. Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver. Exp Hematol. 2015; 43 (6):469-78. doi: 10.1016/j.exphem.2015.03.001 PMID: 25782630